IP Library Granted Patent US 9,670,126
Granted Patent B2
US 9,670,126 · App. 14/527,601 · Granted Jun 6, 2017

Methods of making 15-hydroxy fatty acid derivatives

Inventors: Mehar Manku (Birmingham, GB); David Coughlan (Dublin, IE); Bill Downes (Dublin, IE)
Assignee: DIGNITY SCIENCES LIMITED
C07C59/42C07C51/367
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,670,126
App. No.
14/527,601
Granted
Jun 6, 2017
Kind
B2
Abstract

The present disclosure provides methods of making 15-hydroxy fatty acid derivatives, such as 15-(S)-hydroxyeicosatrienoic acid (HETrE or 15-(S)-HETrE) or 15(S)-hydroxyeicosapentaenoic acid (HEPE or 15(S)-HEPE) from the corresponding fatty acid (e.g., dihomo-γ-linolenic acid (DGLA) or eicosapentaenoic acid (EPA), respectively). In some embodiments, the method comprises contacting the fatty acid with an oxidizing agent (e.g., a lipoxygenase and oxygen) in the presence of a reducing agent (e.g., cysteine) to form the 15-hydroxy fatty acid derivatives in a single reaction vessel.

Claims (17)

1. A process for the production of a15-hydroxy derivative of a fatty acid comprising, oxidizing a fatty acid under an oxygen atmosphere of about 1.1 bar to about 4 bar to form a 15-hydroperoxy fatty acid intermediate and reducing at least a portion of the 15-hydroperoxy fatty acid intermediate using a reducing agent to form a 15-hydroxy derivative of the fatty acid.

2. The process according to claim 1 , wherein the step of oxidizing comprises contacting the fatty acid with less than 400 M units of enzyme per gram of the fatty acid.

3. The process according to claim 1 , producing yield of the 15-hydroxy derivative of the fatty acid of at least about 50%.

4. The process of claim 1 , wherein the 15-hydroxy derivative is 15(S)-HETrE.

5. The process of claim 1 , wherein the 15-hydroxy derivative is 15(S)-hydroxyeicosapentaenoic acid.

6. The process of claim 1 , wherein the reducing agent comprises cysteine.

7. The process of claim 1 , wherein the fatty acid comprises DGLA.

8. The process of claim 1 , wherein the fatty acid comprises a polyunsaturated fatty acid.

9. The process of claim 1 , wherein the 15-hydroxy derivative of the fatty acid has a purity not less than 95% wt/wt.

10. The process of claim 1 , wherein the batch size is not less than 100 kg.

11. The process of claim 1 , wherein the batch size is not less than 250 kg.

12. The process of claim 1 , wherein the batch size is not less than 500 kg.

13. The process of claim 1 , wherein the oxidizing comprises contacting the fatty acid with a soy flour extract.

14. The process of claim 13 further comprising:

contacting soy flour with a buffer solution at pH 4.5 to produce a crude soy flour extract; and

filtering the crude soy flour extract to produce the soy flour extract.

15. The process of claim 14 , wherein the soy flour extract has an activity comparable to about 2 mg/mL of purified, freeze-dried lipoxygenase enzyme.

Assignments (4)
CHANGE OF NAME Recorded Dec 21, 2024
From: DIGNITY SCIENCES LIMITED
To: DS BIOPHARMA LIMITED
Reel/Frame 069659/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2024
From: DS BIOPHARMA LIMITED
To: AFIMMUNE LIMITED
Reel/Frame 069659/0230 →
CHANGE OF NAME Recorded Jul 31, 2017
From: DIGNITY SCIENCES LIMITED
To: DS BIOPHARMA LIMITED
Reel/Frame 043147/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2016
From: MANKU, MEHAR; COUGHLAN, DAVID; DOWNES, BILL
To: DIGNITY SCIENCES LIMITED
Reel/Frame 039280/0461 →
Continuity (2)
Provisional Application 61896901 · Oct 29, 2013
Related Publication 20150119593A1 · Apr 30, 2015